SEC Form 4 · accession 0001179110-18-010359
SELECT MEDICAL HOLDINGS CORP · SEM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael E Tarvin
Officer — Executive Vice President
Period of report
Aug 5, 2018
Accepted (ET)
Aug 7, 2018 · 5:59 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001320414
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 5, 2018 | F | 44,180 | $20.15 | D | 395,864 | D | |
| Common StockF3 | Aug 6, 2018 | S | 39,907 | $20.47 | D | 355,957 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Surrender of shares to satisfy tax withholding obligations incident to vesting of restricted stock.
- F2These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Michael E. Tarvin on November 18, 2016.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $20.15 to $20.70, inclusive. The reporting person undertakes to provide Select Medical Holdings Corporation, any security holder of Select Medical Holdings Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.